Angeles Wealth Management’s AstraZeneca AZN Stock Holding History

Angeles Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Buy	2,383 +207	+10%	+$38.9K	0.02%	298
2026 Q1	$429K	Buy	2,176 +1,006	+86%	+$194K	0.02%	259
2025 Q4	$215K	Buy	+1,170	New	+$205K	0.01%	348
2024 Q1	–	Sell	-1,530	Closed	-$206K	–	297
2023 Q4	$206K	Sell	1,530 -64	-4%	-$8.32K	0.03%	192
2023 Q3	$216K	Buy	+1,594	New	+$218K	0.03%	161

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Angeles Wealth Management's AZN Position: Q2 2026 in Review

Angeles Wealth Management increased its AstraZeneca (AZN) stake by 9.5% in Q2 2026, buying an estimated $38.9K and bringing the position to 2,383 shares worth $451K. The position accounts for 0.02% of the portfolio, ranked #298.

Angeles Wealth Management first reported a position in AZN in Q3 2023 and has held it in 5 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Angeles Wealth Management held 2,383 shares of AstraZeneca worth $451K as of Q2 2026.
Angeles Wealth Management bought 207 AstraZeneca shares in Q2 2026, an estimated $38.9K.
AstraZeneca made up 0.02% of Angeles Wealth Management's portfolio in Q2 2026, its #298 holding.
Angeles Wealth Management first reported a position in AstraZeneca in Q3 2023 and has held it in 5 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.